SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Speculation that SK Hynix may become a major Intel Foundry customer for next-generation HBM base dies is driving attention, with traders viewing a potential deal as validation of Intels foundry turnaround. Some remain cautious because the discussions are unconfirmed, framing the move as a buy the rumor, sell the news setup and awaiting a formal customer announcement.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The approaching 80th death event in SELLASs Phase 3 REGAL AML trial is driving attention, with the official count still reported at 78 of 80 and traders debating whether the prolonged event accrual signals durable GPS benefit. Bullish participants point to long patient survival and supportive comments attributed to pharmaceutical professionals, while skeptics cite potential censoring, control-arm assumptions, trial-design concerns and the binary risk of the final readout.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Bitcoins rally and growing crypto activity are the dominant catalysts, with traders highlighting Robinhood Chain usage, crypto trading volumes, and prediction markets as potential revenue drivers. Bullish participants view the products as supporting further growth, while skeptics point to HOODs high volatility, resistance near recent highs, and frequent selloffs.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Strong quarterly results, improved same-store sales, and raised full-year guidance are fueling renewed optimism that CEO Brian Niccols turnaround is gaining traction. Traders remain divided over whether the recovery is fully priced in, citing Starbucks premium valuation, margin concerns, and ongoing consumer and competitive pressures.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Reported adoption of Helium-powered citywide WiFi in Celina, Texasalongside discussion of AT&T carrier offload and broader mobile-network useis driving the bullish DePIN and real-world utility narrative around HNT. Traders are debating whether the move reflects sustainable network growth or a speculative pump, citing dilution, weak hotspot economics, and possible short-term profit-taking.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Positive Phase 3 Voyage results for DT120 in generalized anxiety disorder, following the earlier MDD success, are driving attention and strengthening expectations for a potential NDA filing after the upcoming Panorama readout. Traders remain broadly bullish on the clinical validation and psychedelic-therapy sector, though some argue the results were partly priced in and debate remission rates, commercialization costs, dilution, and the post-news selloff.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Geopolitical tensions involving Iran, oil and potential market weakness have traders watching UVXY for a volatility spike, but its muted response has fueled debate. Some traders allege VIX suppression or manipulation, while others attribute the divergence to UVXYs VIX-futures exposure, contango and structural decay rather than spot-market volatility.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disneys better-than-expected quarterly earnings, driven by strong parks performance, improving streaming profitability and an expanded share-repurchase plan, are fueling renewed interest and a potential technical breakout. Bulls view the results and new management strategy as evidence of a turnaround, while skeptics point to the slight revenue shortfall, weak stock follow-through and resistance near the 200-day average.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Reported discussions around Chevron expanding its Venezuelan oil operations are driving attention, with traders viewing the company as a potential beneficiary of closer U.S.-Venezuela energy ties and additional production. The community remains divided, as skeptics question the timing, infrastructure constraints, and political uncertainty surrounding any deal.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

Regulatory uncertainty surrounding Hapag-Lloyds proposed acquisitionincluding Israeli national-security concerns and a reported Brazilian antitrust reviewhas kept ZIM in focus, with traders debating whether the deal will close, be delayed, or give way to a competing bid. Bullish investors are emphasizing strong container freight rates, cash generation and future dividends, while skeptics point to the absent quarterly dividend and takeover risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Sell Stocks for July  1st

CZR, RNAC and NSP have been added to the Zacks Rank #5 (Strong Sell) List on July 1, 2026.

Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?

Kiniksa Pharmaceuticals International, plc (KNSA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

These Are the Stocks Traders Are Watching into the Close

As the market enters the final stretch of trading, one story is dominating virtually every trading desk on Wall Street: the historic debut of SpaceX. The company's long-awaited public offering has generated extraordinary volume, massive investor interest, and renewed enthusiasm across multiple high-growth sectors including space infrastructure, artificial intelligence, biotechnology, and advanced communications. $NTHI, $SPCX, $ELVN, $POET, $RNAC, $ALOY

New Partnership Gives Cartesian Therapeutics Another Shot At Autoimmune Disease Market

Cartesian Therapeutics gains after licensing an in vivo CAR-T platform from WestGene, with a myasthenia gravis trial planned for 2026.read more...

Wedbush Reiterates Outperform Rating for Cartesian Therapeutics (NASDAQ:RNAC)

Wedbush restated an "outperform" rating and set a $38.00 price objective on shares of Cartesian Therapeutics in a research report on Friday...

Cartesian Therapeutics (NASDAQ:RNAC) Posts Quarterly Earnings Results

Cartesian Therapeutics (NASDAQ:RNAC - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($1.46) earnings per share for the quarter, missing analysts' consensus...

Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates

Cartesian Therapeutics, Inc. (RNAC) delivered earnings and revenue surprises of -73.81% and -81.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cartesian Therapeutics (RNAC) Projected to Post Earnings on Thursday

Cartesian Therapeutics (NASDAQ:RNAC) will be releasing earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-selecta-biosciences-inc-stock-1...

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) has received an average rating of "Moderate Buy" from the six brokerages that are covering the stock, Marketbeat reports. One equities...

Cartesian Therapeutics, Inc. (RNAC) Soars 10.3%: Is Further Upside Left in the Stock?

Cartesian Therapeutics, Inc. (RNAC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.

Cartesian Therapeutics Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a positive week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$9.60
Prev Close	$9.97
Open	$9.93
Dividend Yield	0.00%
50-Day Moving Average	$9.09
Beta	1.86
Avg. Volume	140,290.35
PE Ratio	-1.62

52-Week High	$11.00
52-Week Low	$5.60
Market Capitalization	$290.45M
EPS (Annual)	-$5.02
Price to Book	-2.30
Revenue Per Employee	$37,293.33

Feed

News

Sentiment

Earnings

Fundamentals

Info